Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 13, 2019

SELL
$90.37 - $122.49 $17,441 - $23,640
-193 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$89.51 - $118.04 $9,219 - $12,158
103 Added 114.44%
193 $23,000
Q1 2019

May 13, 2019

BUY
$61.98 - $96.5 $3,904 - $6,079
63 Added 233.33%
90 $8,000
Q4 2018

Feb 08, 2019

BUY
$56.04 - $82.66 $728 - $1,074
13 Added 92.86%
27 $2,000
Q3 2018

Nov 13, 2018

BUY
$48.29 - $80.6 $676 - $1,128
14 New
14 $1,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Proficio Capital Partners LLC Portfolio

Follow Proficio Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Proficio Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Proficio Capital Partners LLC with notifications on news.